Key takeaways
- Insulin resistance is lipid inside muscle and liver cells; rising insulin hides it behind a normal glucose for years.
- Fasting insulin, HOMA-IR and the triglyceride/HDL ratio catch it years before HbA1c or fasting glucose do.
- Resistance training is first because it enlarges and re-sensitises the largest site of glucose disposal.
- Markers move in order: post-meal glucose within weeks, fasting insulin by month three, HbA1c by month six.
- Reversal is a maintained state, not a completed project — it recedes when the inputs stop.
Insulin resistance is the longest-running silent process in most people's medical history. It typically begins a decade or more before anything abnormal shows up on a standard panel, it drives a large share of what people experience as ordinary middle age, and it responds — genuinely and substantially — to a small number of unglamorous interventions. The reason it is missed is almost always the same: the marker that moves first is not the marker that gets ordered.
What insulin resistance actually is
Insulin's job after a meal is to move glucose into tissue, principally skeletal muscle, while telling the liver to stop making glucose and fat cells to stop releasing fatty acids. Resistance means tissues respond less to a given amount of insulin, so the pancreas makes more.
That compensation is why it stays invisible. Glucose is held normal by rising insulin, sometimes for years. Longitudinal work shows insulin resistance and hyperinsulinaemia arriving well before hyperglycaemia — often eight to fifteen years before a diagnosis (Bogardus et al., Diabetes Care 1993). A normal fasting glucose during that window is not reassurance. It is evidence that the pancreas is still winning a fight nobody has told you about.
Mechanistically the failure happens in specific places, and knowing which ones tells you what to do.
- Skeletal muscle is the largest site of insulin-stimulated glucose disposal. Lipid intermediates accumulating inside muscle fibres impair signalling downstream of the receptor, so glucose transporters are not brought to the cell surface efficiently. Less muscle, and less active muscle, means a smaller sink.
- The liver stops suppressing its own glucose production, so glucose is released even while it arrives from food. Its fat-making pathway stays insulin-sensitive, which is why fatty liver and insulin resistance travel together (fatty liver).
- Adipose tissue, particularly visceral fat, stops restraining fatty acid release and exports free fatty acids and inflammatory signals into the portal circulation.
The common thread is lipid in the wrong place: inside muscle and liver cells rather than inside fat cells. That framing explains why building muscle helps, why losing visceral fat helps disproportionately, and why the same body weight in two people can carry completely different metabolic risk.
Why it matters long before a diagnosis
Chronically elevated insulin is not a neutral state while you wait for glucose to rise. It promotes visceral fat storage, suppresses SHBG and total testosterone in men, drives ovarian androgen production in women, raises triglycerides, lowers HDL and adds to inflammation. Most of what gets called "just getting older" between 35 and 50 is somewhere on that list.
How to measure it properly
| Marker | Optimal | What it tells you |
|---|---|---|
| Fasting insulin | <7 µIU/mL | The earliest routinely available signal. Moves years before glucose. |
| HOMA-IR | <1.5 | Fasting glucose and insulin combined into one index (Matthews et al., Diabetologia 1985) |
| Triglyceride/HDL ratio | <1.5 | A free proxy, calculable from a lipid panel you probably already have |
| HbA1c | <5.4% | Roughly three months of average glucose. Useful, but late. |
| Fasting glucose | <90 mg/dL | The last marker to move. Normal here means very little on its own. |
Most people are given the bottom two rows and nothing else, which is why this is usually caught once the pancreas is already losing. Adding fasting insulin is the single highest-yield change available. See fasting insulin, HOMA-IR and the triglyceride/HDL ratio.
The levers, ranked by mechanism
- Resistance training, three to four days a week. First, for a reason unrelated to weight: it enlarges and re-sensitises the glucose sink, and muscle contraction recruits glucose transporters by an insulin-independent route, so a session works even where insulin signalling is impaired. Improvements of roughly 30-40% in insulin sensitivity are reported independent of weight change (muscle and metabolism). A three-day full-body plan is enough.
- Losing 5-10% of body weight where there is excess. The largest single lever, because visceral and ectopic fat mobilise early and disproportionately. Intensive weight management can drive type 2 diabetes into remission in a meaningful proportion of people — the strongest demonstration that this is reversible rather than permanent (Lean et al., Lancet Diabetes Endocrinol 2019).
- Daily walking, including after meals. Low-intensity contraction uses glucose exactly when it is arriving; a walk after the largest meal is the highest-return ten minutes on this list.
- Protein at every meal. It defends muscle during weight loss — the sink you are relying on — and improves satiety (how much protein).
- Fibre, 30 g or more daily. Slows glucose absorption, blunts the post-meal excursion, and feeds the gut bacteria that produce short-chain fatty acids. Most adults are at half this (the fibre gap).
- Shift carbohydrate quality rather than eliminating it. Refined carbohydrate and liquid sugar produce the excursions that matter; whole-food carbohydrate alongside protein and fibre does not behave the same way.
- Sleep, seven hours or more. Short sleep degrades insulin sensitivity within days in otherwise healthy people, and it does so before anything else in this list has a chance to work (sleep, cortisol and recovery).
- Correct magnesium and vitamin D deficiency if present. These are corrections, not enhancements: supplementing an already adequate level does nothing (magnesium).
Where lifestyle change alone has repeatedly failed to achieve the necessary weight loss, medication is a legitimate part of the conversation (insulin sensitivity beyond weight). Whether it is appropriate is a clinical decision made after individual evaluation.
Order of operations
Doing all of it at once is how people last three weeks. Weeks 1-4, build the floor: fix sleep duration, add a daily walk, get protein to target, and nothing else. Weeks 4-12, add the stimulus: begin resistance training and let it progress, bring fibre up gradually rather than jumping to 30 g overnight, and only now manage total energy intake. From month 3, measure and adjust — repeat fasting insulin and the lipid panel, and if markers have not moved despite genuine adherence, look upstream at thyroid, cortisol, sex hormones and sleep apnoea rather than trying harder at the same thing.
What to expect, and when
| Time | Typical change |
|---|---|
| Week 1-2 | Post-meal glucose excursions flatten, most after the meals followed by a walk. Nothing visible on a fasting panel yet. |
| Week 4 | Fasting glucose down a few mg/dL. Energy and post-meal alertness usually improve before any number does. |
| Month 3 | Fasting insulin down substantially — falls of 30-50% are common — and HOMA-IR roughly halving. This is the first hard confirmation. |
| Month 6 | HbA1c down a few tenths of a point; triglyceride/HDL ratio normalising; liver enzymes improving if they were raised. |
| Month 12 | Many adults have restored insulin sensitivity to a normal range and hold it, provided the muscle and the habits are maintained. |
The hormonal two-way street
Insulin resistance is both a cause and a consequence of hormonal disruption, which is why treating one side alone often disappoints.
In men, insulin resistance lowers SHBG and total testosterone, and low testosterone worsens body composition and insulin sensitivity in turn. Testosterone therapy in men with deficiency and metabolic syndrome has been associated with improved insulin sensitivity beyond what weight change explains (Tishova et al., Diabetes Obes Metab 2024); see testosterone and insulin sensitivity. In women it drives ovarian androgen excess and is the engine of the PCOS phenotype, while falling oestrogen in perimenopause worsens sensitivity independently. Addressing only one end is usually why nothing moves.
The clinical pearl: muscle is the organ that disposes of most of your glucose, so any weight-loss plan that costs you muscle is working against its own objective. Protein and resistance training are not optional additions to a metabolic protocol — they are what determines whether the weight you lose improves the condition or quietly worsens it.
What "reversal" honestly means
Insulin sensitivity can be restored to a normal range. The underlying tendency — genetic, and in some populations strongly so — does not go away. Remission is held by the behaviours that produced it and recedes when they stop, which is why regain reliably takes the markers back the way they came. Landmark prevention work found intensive lifestyle change outperformed medication at reducing progression to diabetes, and the operative words were "intensive" and sustained (Knowler et al., N Engl J Med 2002). Reversal is a maintained state, not a completed project.
Bottom line
Insulin resistance is lipid accumulating where it does not belong — in muscle and liver — and the compensating rise in insulin hides it from a standard panel for years. Order fasting insulin, calculate HOMA-IR and read the triglyceride/HDL ratio you already have, rather than waiting for glucose to break. Then work the mechanism: build and use muscle, reduce visceral fat, walk after meals, get protein and fibre to target, sleep. Markers move in order — post-meal glucose within weeks, fasting insulin by month three, HbA1c by month six — and remission lasts only as long as the inputs do. Where hormones are part of the loop, both ends need attention; a proper evaluation sorts that out.
Educational content, not medical advice. Laboratory interpretation and any treatment decision are made by a licensed physician after individual evaluation. Individual results vary.
